Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia.
Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA. Huntington SF, et al. Among authors: kamal bahl s. Leuk Lymphoma. 2023 Dec;64(14):2286-2295. doi: 10.1080/10428194.2023.2256911. Epub 2023 Dec 25. Leuk Lymphoma. 2023. PMID: 37870435 Free article.
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting.
Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF. Garg M, et al. Among authors: kamal bahl s. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):e181-e190. doi: 10.1016/j.clml.2024.01.010. Epub 2024 Feb 9. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38433043 Free article.
Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting.
Huntington SF, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Doshi JA. Huntington SF, et al. Among authors: kamal bahl s. J Manag Care Spec Pharm. 2024 Oct;30(10):1106-1116. doi: 10.18553/jmcp.2024.24049. Epub 2024 Jul 24. J Manag Care Spec Pharm. 2024. PMID: 39046941 Free PMC article.
46 results